rs76334696
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1
The NM_012144.4(DNAI1):c.1604C>A(p.Thr535Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00654 in 1,614,238 control chromosomes in the GnomAD database, including 278 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T535A) has been classified as Uncertain significance.
Frequency
Consequence
NM_012144.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.1604C>A | p.Thr535Asn | missense_variant | 17/20 | ENST00000242317.9 | |
DNAI1 | NM_001281428.2 | c.1616C>A | p.Thr539Asn | missense_variant | 17/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.1604C>A | p.Thr535Asn | missense_variant | 17/20 | 1 | NM_012144.4 |
Frequencies
GnomAD3 genomes AF: 0.00763 AC: 1162AN: 152238Hom.: 29 Cov.: 32
GnomAD3 exomes AF: 0.0154 AC: 3861AN: 251334Hom.: 102 AF XY: 0.0168 AC XY: 2277AN XY: 135838
GnomAD4 exome AF: 0.00643 AC: 9395AN: 1461882Hom.: 249 Cov.: 32 AF XY: 0.00771 AC XY: 5605AN XY: 727240
GnomAD4 genome AF: 0.00761 AC: 1160AN: 152356Hom.: 29 Cov.: 32 AF XY: 0.00985 AC XY: 734AN XY: 74504
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:4
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Thr535Asn in exon 17 of DNAI1: This variant is not expected to have clinical sig nificance because it has been identified in 5.9% (11/186) of Finnish chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.go v/projects/SNP; dbSNP rs76334696). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 23, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at